Navigation Links
UofL researcher earns the Foundation for Polish Science Prize
Date:1/13/2012

Inflammation of gum tissues periodontitis is one of the most common infectious diseases. Those affected are more susceptible to diseases of the circulatory system, rheumatoid arthritis, aspiration pneumonia or premature birth.

The findings of Jan Potempa, PhD, DSc, professor and academic scholar, Oral Health and Systemic Disease group, University of Louisville School of Dentistry, have helped change scientific thinking about the origin of periodontal tissue inflammation. The results of his research may lead to the development of more effective medication to combat periodontal disease, and therefore reduce the risk of heart disease and arthritis.

Potempa conducts his research both at the University of Louisville and at Jagiellonian University in Krakow, Poland. His discoveries have earned him the Foundation for Polish Science Prize in the field of life sciences. The FNP Life Sciences Prize is given annually to one Polish researcher for outstanding achievements or discoveries.

"The FNP Prize is regarded as the most prestigious of its kind in Poland, and we are so proud to have such a prominent researcher on our team," said Donald Demuth, PhD, acting associate dean for research and enterprise, UofL School of Dentistry. "During his career, Jan's work has been supported by the National Institutes of Health, the Polish Ministry of Science and Higher Education and the European Union. He has authored 278 publications and holds 11 patents."

Potempa's Discoveries

Potempa's research deals with the role of the bacteria Porphyromonas gingivalis, in the formation and development of periodontal disease. Potempa and his team isolated and identified seven protein-degrading enzymes produced by these bacteria including the so-called gingipain enzymes.

He found that gingipain enzymes facilitate the development of gum tissue inflammation, underscoring their responsibility for hindering positive autoimmune reactions. Instead of eliminating the bacteria, they turn against the body's own tissues. This results in chronic inflammation of the gum tissue and leads to destruction of gum and bone, causing tooth loss.


'/>"/>

Contact: Julie Heflin
julie.heflin@louisville.edu
502-852-7987
University of Louisville
Source:Eurekalert

Related biology news :

1. Researchers identify possible receptor for key breast cancer regulator
2. UH Manoa researchers discover novel chemical route to form organic molecules
3. Researchers: Honeybee deaths linked to seed insecticide exposure
4. Worm seeks worm: Caltech researchers find chemical cues driving aggregation in nematodes
5. La Jolla Institute researchers identify pivotal immune cell in Type 1 diabetes in humans
6. Boston University School of Medicine researchers clarify link between salt and hypertension
7. New findings by St. Michaels researchers about the way cells work
8. Tapping the bodys own defenses, researchers look to cutting-edge gene therapy for bladder cancer
9. Researchers discover novel anti-viral immune pathway in the mosquito
10. GW researcher and colleagues identify environmental exposure to organochlorines may impact male reproduction
11. MU researchers find unique protein organization in arteries associated with cardiovascular disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 24, 2017  EyeLock LLC, a leader ... its elite iris biometric solution on the latest ... LTE at Mobile World Congress 2017 (February ... Booth in Hall 3, Stand 3E10. ... Qualcomm Haven™ security platform—a combination of hardware, ...
(Date:2/21/2017)... and PORTLAND, Ore. , ... and the Avamere Family of Companies (Avamere Health Services, ... announced a six-month research study that will apply the ... eldercare at senior living and health centers. By analyzing ... hopes to gain insights into physical and environmental conditions, ...
(Date:2/16/2017)... Feb. 16, 2017  Genos, a community for ... it has received Laboratory Accreditation from the College ... presented to laboratories that meet stringent requirements around ... rigorous processes. "Genos is committed to ... practices. We,re honored to be receiving CAP accreditation," ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... , March 22, 2017 The ... states a research report by Transparency Market Research (TMR). ... Amgen Inc., and AbbVie Inc., accounted for a share ... prominent players in this market are focusing aggressively on ... portfolio, which is likely to lead to market consolidation ...
(Date:3/22/2017)... , March 22, 2017 /PRNewswire/ - FACIT announced ... "Company" or "Propellon"), a start-up created by FACIT ... therapeutics. FACIT,s investment, combined with non-dilutive capital, achieves ... The seed funding enables Propellon to accelerate the ... Company for financing and/or entering a strategic partnership ...
(Date:3/22/2017)... , March 22, 2017   VWR ... provider of product and service solutions to ... it has acquired EPL Archives, Inc., an ... across the entire regulated product research, development ... document storage and ancillary services. EPL Archives ...
(Date:3/22/2017)... ... 21, 2017 , ... Okyanos Cell Therapy has announced Tallahassee, FL will be ... series, “Stem Cell Therapy: The Next Phase in the Evolution of Medicine.” As the ... Research and Therapy Act, Okyanos maintains a mission to help “no-option” patients and ...
Breaking Biology Technology: